Several UCHL1 substrates have been described in tumour cells including Epidermal Growth Factor Receptor (EGFR), Transforming Growth Factor β (TGF-β), SMAD2, and importantly for our current study, Hypoxia Inducible Factor 1 α (HIF1α) [7–9]. This evidence concerns the gene EGFR and neoplasm.